Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Alan M. HobermanDirector | BioxytranBIXT | Open-market buy | 25/11/18 | 25/11/18 | 210,000 sh | $0.60 | $126,000 | No record |
David PlattCEO | BioxytranBIXT | Open-market buy | 24/08/15 | 24/08/20 | 1,592,921 sh | $0.12 | $191,150.52 | +7.9% |